Launch of SureSeq Myeloid plus Panel and Universal NGS Complete Workflow
Enhanced NGS portfolio includes Interpret Software updates and enables rapid and confident variant detection
Articles by Oxford Gene Technology
OGT Expands NGS Cancer Panel Offering
Launch of two NGS panels enables comprehensive detection of genetic abnormalities involved in breast and ovarian cancer, and myeloid disorders
OGT Delivers Translocation and Partial Tandem Duplication Detection with Updates to SureSeq NGS Portfolio
New content and Interpret NGS analysis software detection capabilities include BCR-ABL and KMT2A-PTD detection
OGT Unveils Reliable Somatic CNV Detection for CLL with New NGS Panel
SureSeq™ CLL + CNV—comprehensive CLL genomic profiling from a single assay
OGT Develops Transformative Constitutional NGS Panel
CytoSure NGS—Combining the benefits of microarrays and NGS in a single assay
OGT Makes Market-Leading NGS Coverage and Expertise More Accessible
SureSeq complete library preparation solution delivers unparalleled data quality
OGT launches enhanced SureSeq™ Interpret NGS Analysis Software
Powerful, flexible, and easy-to-use analysis solution gets the most out of NGS data
OGT Expands Direct Sales and Support Infrastructure in Europe
Customers to benefit from Sysmex’s extensive operational footprint
OGT Expands Custom NGS Cancer Panel Content and Readies Enhanced Software for Release
Increased content provides even more flexibility for customization